United Therapeutics (UTHR) Tops Q3 EPS by 23c
Tweet
Share
E-mail
Get Alerts UTHR Hot Sheet
Price: $512.88 -0.05%
Financial Fact:
Total operating expenses: 169.6M
Today's EPS Names:
XYF, SQZB, RENO, More
Financial Fact:
Total operating expenses: 169.6M
Today's EPS Names:
XYF, SQZB, RENO, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q3 EPS of $5.38, $0.23 better than the analyst estimate of $5.15. Revenue for the quarter came in at $609.4 million versus the consensus estimate of $587.9 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Broadcom credit risk measures rise amid AI financing deals
- FDA accepts United Therapeutics NDA for ralinepag PAH treatment
- Gogoro Inc (GGR) Reports Q2 Loss of $0.24, Offers FY26 Revenue Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
